Research study Program year 2020 Source: CMS Open Payments

TRTN 1619

Research payments

$664,986

22 payments

Through program year 2020, $664,986 in research payments was reported against TRTN 1619, across 22 payments, paid by Taro Pharmaceuticals USA, Inc..

Paid by: Taro Pharmaceuticals USA, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2020	Research	$664,986	22

Breakdown

Who paid Research payments · program year 2020

Taro Pharmaceuticals USA, Inc. $664,986 22 payments

Who received the money Research payments · program year 2020

Moore Clinical Research, Inc. Organisation paid for research $216,527 5 payments
3A Research, LLC Organisation paid for research $148,635 7 payments
Fxm Clinical Research Miami Llc Organisation paid for research $139,501 4 payments
Fxm Clinical Research Miramar LLC Organisation paid for research $139,003 4 payments
Dfw Clinical Research Organisation paid for research $21,321 2 payments

Usually the institution or organisation running the study, not a person.

What the money was spent on Research payments · program year 2020

Professional salary support $664,986 22 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

5 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.